Amit Dutt
Amit Dutt
Principal Investigator/ Wellcome Trust DBT India Alliance Int Fellow, ACTREC, Tata Memorial Centre
Verified email at actrec.gov.in - Homepage
Title
Cited by
Cited by
Year
Somatic mutations affect key pathways in lung adenocarcinoma
L Ding, G Getz, DA Wheeler, ER Mardis, MD McLellan, K Cibulskis, ...
Nature 455 (7216), 1069-1075, 2008
27252008
High-throughput oncogene mutation profiling in human cancer
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
10872007
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ...
Nature genetics 41 (11), 1238-1242, 2009
9332009
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer
PS Hammerman, ML Sos, AH Ramos, C Xu, A Dutt, W Zhou, LE Brace, ...
Cancer discovery 1 (1), 78-89, 2011
5282011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer
A Dutt, AH Ramos, PS Hammerman, C Mermel, J Cho, T Sharifnia, ...
PloS one 6 (6), e20351, 2011
4102011
Drug-sensitive FGFR2 mutations in endometrial carcinoma
A Dutt, HB Salvesen, TH Chen, AH Ramos, RC Onofrio, C Hatton, ...
Proceedings of the National Academy of Sciences 105 (25), 8713-8717, 2008
3752008
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
HB Salvesen, SL Carter, M Mannelqvist, A Dutt, G Getz, IM Stefansson, ...
Proceedings of the National Academy of Sciences 106 (12), 4834-4839, 2009
3142009
A structure-guided approach to creating covalent FGFR inhibitors
W Zhou, W Hur, U McDermott, A Dutt, W Xian, SB Ficarro, J Zhang, ...
Chemistry & biology 17 (3), 285-295, 2010
1852010
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer
V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ...
Journal of Clinical Oncology 38 (2), 124-136, 2020
1422020
Single nucleotide polymorphism array analysis of cancer
A Dutt, R Beroukhim
Current opinion in oncology 19 (1), 43-49, 2007
1362007
Amplification of chromosomal segment 4q12 in non-small cell lung cancer
AH Ramos, A Dutt, C Mermel, S Perner, J Cho, CJ Lafargue, LA Johnson, ...
Cancer biology & therapy 8 (21), 2042-2050, 2009
922009
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity
A Chougule, K Prabhash, V Noronha, A Joshi, A Thavamani, P Chandrani, ...
PloS one 8 (10), e76164, 2013
802013
Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes
I Mittra, NK Khare, GV Raghuram, R Chaubal, F Khambatti, D Gupta, ...
Journal of biosciences 40 (1), 91-111, 2015
792015
EGF signal propagation during C. elegans vulval development mediated by ROM-1 rhomboid
A Dutt, S Canevascini, E Froehli-Hoier, A Hajnal, J Ahringer
PLoS biology 2 (11), e334, 2004
742004
A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley
I Murtaza, D Mushtaq, MA Margoob, A Dutt, NA Wani, I Ahmad, ML Bhat
World journal of gastroenterology: WJG 12 (25), 4033, 2006
732006
Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies
J Cho, S Pastorino, Q Zeng, X Xu, W Johnson, S Vandenberg, R Verhaak, ...
Cancer research 71 (24), 7587-7596, 2011
712011
MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes
B Rekhi, P Upadhyay, MP Ramteke, A Dutt
Modern Pathology 29 (12), 1532-1540, 2016
602016
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy
V Noronha, K Prabhash, A Thavamani, A Chougule, N Purandare, A Joshi, ...
PLoS One 8 (4), e61561, 2013
592013
Impact of common diabetes risk variant in MTNR1B on sleep, circadian, and melatonin physiology
JM Lane, AM Chang, AC Bjonnes, D Aeschbach, C Anderson, BE Cade, ...
Diabetes 65 (6), 1741-1751, 2016
582016
Actionable activating oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain mutations
KB Pahuja, TT Nguyen, BS Jaiswal, K Prabhash, TM Thaker, K Senger, ...
Cancer Cell 34 (5), 792-806. e5, 2018
562018
The system can't perform the operation now. Try again later.
Articles 1–20